FAS and breast carcinoma: In summary, our current study demonstrated that α-mangostin, a potent FAS inhibitor, down-regulated FAS expression, inhibited intracellular FAS activity, decreased the amount of intracellular fatty acid and thus induced apoptosis in human breast cancer cells.